Factors Independently Related to Overall Survival in 1,710 Cases of Diffuse Large-Cell Lymphoma
| Factor . | Relative Risk . | P . |
|---|---|---|
| Age (≤60 v >60) | 1.72 | <.0001 |
| Ann Arbor stage (I-II v III-IV) | 1.60 | <.0001 |
| LDH level (≤1 × normal v >1 × normal) | 1.59 | <.0001 |
| Performance status (0-1 v 2-4) | 1.59 | <.0001 |
| Histology (anaplastic v nonanaplastic) | 1.60 | .0028 |
| B symptoms (no v yes) | 1.07 | .0097 |
| Serum albumin level (≤30 g/L v <30 g/L) | 1.21 | .01 |
| Bone marrow involvement (no v yes) | 1.04 | .036 |
| Extranodal involvement (≤1 site v >1 site) | 1.18 | .05 |
| Factor . | Relative Risk . | P . |
|---|---|---|
| Age (≤60 v >60) | 1.72 | <.0001 |
| Ann Arbor stage (I-II v III-IV) | 1.60 | <.0001 |
| LDH level (≤1 × normal v >1 × normal) | 1.59 | <.0001 |
| Performance status (0-1 v 2-4) | 1.59 | <.0001 |
| Histology (anaplastic v nonanaplastic) | 1.60 | .0028 |
| B symptoms (no v yes) | 1.07 | .0097 |
| Serum albumin level (≤30 g/L v <30 g/L) | 1.21 | .01 |
| Bone marrow involvement (no v yes) | 1.04 | .036 |
| Extranodal involvement (≤1 site v >1 site) | 1.18 | .05 |